TriangleNCT01434342 · STUDY IN CONTEXT
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Draft scope assessment: narrower. Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. The condition was transformed or resolved through the terminology hierarchy to reach this cancer type, so the link itself is a candidate a reviewer must confirm. Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.
Read the full study record and all posted results →
Linked outcomes
The primary feasibility measures are retention and adherence. This outcome, retention, is the percentage of patient who remain in the study for 24 weeks.
Adherence is measured by the percentage of randomized participants who have a Quitline call. Note that this outcome is only defined for the Intervention arm
Reported safety
Quality of life and patient-reported measures
No linked quality-of-life measure is recorded for this setting and study.
Full draft applicability and source-link record
- trial
- release id
- clinical-indications-draft-1
- disease state id
- ds-lung-carcinoma
- nct id
- NCT01434342
- trial label
- Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
- applicability
- narrower
- applicability note
- Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. The condition was transformed or resolved through the terminology hierarchy to reach this cancer type, so the link itself is a candidate a reviewer must confirm.
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- provenance class
- registry-condition-search
- discovery note
- Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.
- outcome Count
- 2
- harms Count
- 2
- qol Count
- 0
- outcomes
- release id
- clinical-indications-draft-1
- disease state id
- ds-lung-carcinoma
- nct id
- NCT01434342
- outcome key
- om-0000
- source section id
- NCT01434342-om-0000
- source outcome index
- 0
- endpoint
- Feasibility of a Smoking Cessation Intervention Among Cancer Patients
- endpoint definition
- The primary feasibility measures are retention and adherence. This outcome, retention, is the percentage of patient who remain in the study for 24 weeks.
- time origin
- 24 Weeks
- analysis role
- primary
- reporting status
- POSTED
- data cutoff
- Source null
- population note
- All randomized participants
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- release id
- clinical-indications-draft-1
- disease state id
- ds-lung-carcinoma
- nct id
- NCT01434342
- outcome key
- om-0001
- source section id
- NCT01434342-om-0001
- source outcome index
- 1
- endpoint
- Adherence
- endpoint definition
- Adherence is measured by the percentage of randomized participants who have a Quitline call. Note that this outcome is only defined for the Intervention arm
- time origin
- 24 weeks
- analysis role
- primary
- reporting status
- POSTED
- data cutoff
- Source null
- population note
- All randomized participants
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- arms
- release id
- clinical-indications-draft-1
- disease state id
- ds-lung-carcinoma
- nct id
- NCT01434342
- outcome key
- om-0000
- arm key
- OG000
- arm label
- Arm I - Quitline
- regimen
- Participants receive a letter from their physician advising them to quit smoking, and undergo a 15-30-minute smoking-cessation counseling session by a trained research staff. The participants are educated and motivated about the importance of quitting smoking, and cancer-specific quitting issues. They will be called by Quitline in 2-3 days and receive a fact sheet about benefits of SC for cancer patients. Participants receive 8 weeks of nicotine replacement patches and up to 5 proactive telephone calls over a 12-week period. Participants also learn behavioral tips and coping skills.
- analyzed count
- 98
- analyzed unit
- Participants
- is comparator
- Source null
- source pointer
- NCT01434342-om-0000#groups/OG000
- release id
- clinical-indications-draft-1
- disease state id
- ds-lung-carcinoma
- nct id
- NCT01434342
- outcome key
- om-0000
- arm key
- OG001
- arm label
- Arm II - Usual Care
- regimen
- Participants receive a letter from their physician advising them to quit smoking, the importance of quitting smoking for cancer patients, and a copy of the National Cancer Institute's "Clearing the Air" smoking cessation booklet. Participants also receive standard of care from their oncology and other treatment providers which may or may not include nicotine replacement therapy.
- analyzed count
- 48
- analyzed unit
- Participants
- is comparator
- Source null
- source pointer
- NCT01434342-om-0000#groups/OG001
- release id
- clinical-indications-draft-1
- disease state id
- ds-lung-carcinoma
- nct id
- NCT01434342
- outcome key
- om-0001
- arm key
- OG000
- arm label
- Arm I - Quitline
- regimen
- Participants receive a letter from their physician advising them to quit smoking, and undergo a 15-30-minute smoking-cessation counseling session by a trained research staff. The participants are educated and motivated about the importance of quitting smoking, and cancer-specific quitting issues. They will be called by Quitline in 2-3 days and receive a fact sheet about benefits of SC for cancer patients. Participants receive 8 weeks of nicotine replacement patches and up to 5 proactive telephone calls over a 12-week period. Participants also learn behavioral tips and coping skills.
- analyzed count
- 98
- analyzed unit
- Participants
- is comparator
- Source null
- source pointer
- NCT01434342-om-0001#groups/OG000
- release id
- clinical-indications-draft-1
- disease state id
- ds-lung-carcinoma
- nct id
- NCT01434342
- outcome key
- om-0001
- arm key
- OG001
- arm label
- Arm II - Usual Care
- regimen
- Participants receive a letter from their physician advising them to quit smoking, the importance of quitting smoking for cancer patients, and a copy of the National Cancer Institute's "Clearing the Air" smoking cessation booklet. Participants also receive standard of care from their oncology and other treatment providers which may or may not include nicotine replacement therapy.
- analyzed count
- 0
- analyzed unit
- Participants
- is comparator
- Source null
- source pointer
- NCT01434342-om-0001#groups/OG001
- harms
- release id
- clinical-indications-draft-1
- disease state id
- ds-lung-carcinoma
- nct id
- NCT01434342
- harm key
- EG000
- source section id
- NCT01434342-ae
- event group key
- EG000
- event group label
- Arm I - Quitline
- serious affected
- 14
- serious at risk
- 75
- other affected
- 61
- other at risk
- 75
- frequency threshold
- 5
- collection period
- 24 weeks
- event definition
- Sample size is the number of participants with follow-up toxicity data
- undenominated note
- Source null
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- release id
- clinical-indications-draft-1
- disease state id
- ds-lung-carcinoma
- nct id
- NCT01434342
- harm key
- EG001
- source section id
- NCT01434342-ae
- event group key
- EG001
- event group label
- Arm II - Usual Care
- serious affected
- 5
- serious at risk
- 37
- other affected
- 33
- other at risk
- 37
- frequency threshold
- 5
- collection period
- 24 weeks
- event definition
- Sample size is the number of participants with follow-up toxicity data
- undenominated note
- Source null
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- quality of life
- setting source links
Preserved source evidence · Not medical advice